CoChat
Sign Up
Cited by 64Nanoplatforms for cancer theranosticsGold and Silver Nanoparticles Synthesis and ApplicationsNanoparticle-Based Drug Delivery

The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.

The theranostic potential of green nanotechnology-enabled gold nanoparticles in cancer: A paradigm shift on diagnosis and treatment approaches

Open access
Sakore, Preeti, Bhattacharya, Sankha, Belemkar, Sateesh, Prajapati, Bhupendra G., Elossaily, Gehan M.·2024·Results in Chemistry
DOI 10.1016/j.rechem.2023.101264
Open this paper in CoChat — free account

Abstract

The application of nanotechnology to cancer research has resulted in substantial advancements. In this study, gold nanoparticles (AuNPs) synthesised utilising environmentally friendly methods are evaluated for their potential as multipurpose theranostic agents in cancer treatment. These eco-friendly AuNPs are attractive candidates for theranostic applications that combine diagnosis and therapy due to their specific physicochemical features. Green nanotechnology practises that use only sustainable, biocompatible materials promote biocompatibility in biomedical applications while reducing environmental impact. Imaging techniques such as optical coherence tomography, surface-enhanced Raman scattering, and photoacoustic imaging can benefit from AuNPs in part due to their optical properties. Their surface plasmon resonance (SPR) can be adjusted, improving imaging contrast and allowing for tailored administration of therapeutic payloads. The localised SPR effect of AuNPs also increases the efficacy of photothermal treatment (PTT) by converting near-infrared light into localised heat and inducing hyperthermia in cancer cells. Because of the localised heating, the cancer may be ablated precisely and with minimal collateral damage. AuNPs can be observed and assessed in real time as part of a multimodal imaging platform, in addition to being used as diagnostic and therapeutic tools. The primary focus of this research is on recent breakthroughs in the production of AuNPs using green nanotechnology techniques, particularly those that have occurred beyond 2020, and their potential applications in cancer theranostics. We are investigating various techniques for functionalizing AuNPs with specific ligands, medications, and imaging agents in order to improve therapeutic efficacy. We also go over the regulatory considerations and toxicity assessments that must be considered when bringing these nanomaterials into clinical use, as well as the potential that exist.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.rechem.2023.101264

Cites

101 of 101 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cited works that were retracted

Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.

1 of 1

Citations

Cites

1 retracted

Research works printed but not linked: 3

  1. Daniel, 2004, Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catal. Nanotechnol., 104, 293
  2. Peng, 2019, Progress in research on gold nanoparticles in cancer management, Medicine, 98, 10.1097/md.0000000000015311 · DOI
  3. Manohar, N. and S.H. Cho. Quality of micro-CT images acquired from simultaneous micro-CT and benchtop x-ray fluorescence computed tomography (XFCT): A preliminary Monte Carlo study. in 2013 IEEE Nuclear Science Symposium and Medical Imaging Conference (2013 NSS/MIC). 2013. IEEE.

Cited by

Sorted by citations

See all 64

Related

See all

Metadata

Authors
Sakore, P., Bhattacharya, S., Belemkar, S., Prajapati, B. G., & Elossaily, G. M.
Affiliations
  • Narsee Monjee Institute of Management Studies (IN)
  • Ganpat University (IN)
  • Almaarefa University (SA)
Corresponding author
Bhattacharya, Sankha
ORCID
Venue
Results in Chemistry
Publisher
Elsevier BV
Published
2024-01
Volume
7
Pages
101264
ISSN
2211-7156 (ISSN-L)
DOI
10.1016/j.rechem.2023.101264
OpenAlex
W4389849742
Semantic Scholar
718a44dbcde12d3a13399df88402484d59115b1d
Cited by
64
References
101
Citations by year
2026: 18 · 2025: 24 · 2024: 22
FWCI
4.36
Type
journal article
Language
en
Open access
Licence
Locations
  • Results in Chemistry (publishedVersion, cc-by-nc-nd)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
  • Physical Sciences › Materials Science › Electronic, Optical and Magnetic Materials › Gold and Silver Nanoparticles Synthesis and Applications
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Keywords
gold nanoparticles, green synthesis, theranostics, cancer diagnosis, cancer therapy, surface plasmon resonance, photothermal therapy, hyperthermia, optical imaging, surface-enhanced Raman scattering, photoacoustic imaging, optical coherence tomography, nanoparticle functionalization, nanomaterial toxicity, nanomaterial regulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review